Tao Li, Jing Li, Yang Yang, Yilin Han, Dirong Wu, Tao Xiao,Yang Wang, Ting Liu, Yonglong Zhao, Yongjun Li, Zeqin Dai,Xiaozhong Fu*Synthesis, pharmacological evaluation, and mechanistic study of adefovir mixed phosphonate derivatives bearing cholic acid and L-amino acid moieties for the treatment of HBV.Bioorg Med Chem2019,27,3707–3721
4. Yongxi Dong, Li Dong,Jinglei Chen, Min Luo,Xiaozhong Fu*, Chunhua Qiao Synthesis and biological evaluation of N-alkyl-1,4-dihydroquinoline prodrugs of scutellarin methyl ester as neuroprotective agents.Med Chem Res.2018, 27, 1111-1121.
5. Ya Chen, Wen Zheng Zhang, Jing Li, Tao Xiao, Jiang Xia Liu, Min Luo, Hang Su,Xiao-Zhong Fu*, Ting Liu, Yong-Xi Dong, Yong-Long Zhao, Bin He, Yong-Jun Li. Novel adefovir mono L-amino acid ester, mono bile acid ester derivatives: Design, synthesis, biological evaluation, and molecular docking study.Med Chem Res.2017, 26, 1812-1821.
6.Yu Ou, Min Luo, Yong-Xi Dong, Hang Su,Xiao-Zhong Fu*, Yu-Feng Cha,Shun Zhang, Yong-Long Zhao, Yong-Jun Li, Yong-Lin Wang.Permeability of novel 4′-N-substituted (aminomethyl) benzoate-7- substituted nicotinic acid ester derivatives of scutellarein in Caco-2 cells and in an invitro model of the blood-brain barrier.Med Chem Res.2016, 25,2205-2213.
7.Yu-Feng Cha, Shun Zhang, Hang Su, Yu Ou,Xiao-Zhong Fu*, Feng-Jie Jiang,Yong-Long Zhao, Yong-Xi Dong, Min Luo, Yong Huang,Yan-Yu Lan, Ai-Min Wang, Yong-Lin Wang. L-Aminoacid carbamate prodrugs of scutellarin: synthesis, physiochemical property,Caco-2 cell permeability, and In Vivo anti-oxidative activityMed Chem Res.2015, 24, 2238-2246.
8. Ze-Qin Dai, Hang Su, Min Luo, Yu Ou,Xiao-Zhong Fu*,Yu-Feng Cha, Shun Zhang, Yong Huang, Yong-Lin Wang. Applicationof N-substituted (aminomethyl) benzoate Strategy in Design of ScutellareinDerivatives with Improved Caco-2 Cell Permeability and In vitro AntioxidativeActivityBull K Chem Soc2015, 36,1959-1965.
9.Xiaozhong Fu*, FengjieJiang, Yu Ou, Sheng Fu, Yufeng Cha, Shun Zhang, Zongyuan Liu, Wen Zhou,Yonglin Wang* Synthesis and anti-HBV evaluation of mono L-amino acidester, mono non-steroid anti-inflammation drug carboxylic ester derivatives ofacyclonucleoside phosphonates.Chin Chem Lett2014,25,115-118
10.FengjieJiang,Xiaozhong Fu*, Shanwu Wang, Yong Huang, Wen Zhou, Aimin Wang and Yonglin Wang*.Synthesis and physiochemical property evaluationof carbamate derivatives of scutellarin methyl esterChin Chem Lett2013, 24, 338-340
11.Xiao-Zhong Fu, Yu Ou,Jian-Ying Pei,Ying Liu, Jing Li, Wen Zhou, Yan-Yu Lan, Ai-Min Wang and Yong-Lin Wang *. Synthesis, anti-HBV activityand renal cell toxicity evaluation of mixed phosphonate prodrugs ofadefovirEur J Med Chem2012, 49,211-218.
12.Xiao Zhong Fu, Yu Ou, Jian Xin, Yu She Yang*. Design,synthesis and in vivo evaluation of mono (2,2,2- tri- fluoroethyl) esters, monoL-amino acid ester prodrugs of acyclic nucleoside phosphonates as anti-HBVagents.Chin Chem Lett2011, 22,1387-1390.
13.Xiao-ZhongFu, Feng-Jing Xing, Yan-Yu Lan, Ai-Min Wang, Yong-Lin Wang,* Jing Li, Wen Zhou, Wei Zhang, Ying Liu. Synthesis and in vitroanti-oxidative activity studies of 4’-N-substituted (amino methyl) benzoatederivativesof Scutellarein.Chin J Org Chem,2011,31(7) : 1043-1048.
14.Xiao-Zhong Fu*, Ying Huang, Zhu Tao, Sai-Feng Xue, Chun Luo, Yu Ou, Jian-XinZhang. Investigation of Complex of Cucurbit[6, 7, 8]urils with AdefovirBis(L-amino acid) Ester Prodrug and Its Anti-HBV Activity.Chin J Org Chem2010, 30 (5):675-683.
15.Xiaozhong Fu, SaihongJiang, Peng Lu, Yushe Yang*, Ruyun Ji. An improved synthetic process for YF-6,A promising anti-HBV drug candidate.Org Prep Proced In2008, 40 (5): 467-470.
16.Xiaozhong Fu, SaihongJiang, Chuan Li, Jian Xin, Yushe Yang*, Ruyun Ji. Design and synthesis of novelbis(L-amino acid) ester prodrugs of 9-[2- (phosphono methoxy) ethyl] adenine(PMEA) with improved anti-HBV activity.Bioorg. Med Chem Lett2007, 17(2): 465-470.
17.Xiaozhong Fu, Sai Hong Jiang, Jian Xin, Yushe Yang*. Design,synthesis and in vitro Evaluation of L-amino acid esters prodrugs of acyclicnucleoside phosphonates as anti-HBV agent.Chin Chem Lett2007,18(7): 817-819.
(二)获得授权发明专利情况
1.傅晓钟;王永林;苏航;兰燕宇;李勇军;王爱民;黄勇;陈雅;罗敏;张文政 阿德福韦单硫代L-氨基酸酯单胆酸酯衍生物及其制备方法 获得授权发明专利 专利授权号:ZL 201610427712.0。授权时间2020.5.22
2.杨玉社,傅晓钟,李战,嵇汝运嘌呤类化合物双氨基酸酯的制备方法与用途。授权时间2011.2.16,中国,专利授权号:ZL200610024401.6。
3.杨玉社,傅晓钟,李战,嵇汝运用于治疗乙型肝炎的嘌呤类化合物及其制备方法和用途。授权时间2011.9.21,中国,专利授权号:ZL200610027328.8。
(三)获得奖励情况
1、傅晓钟,黄英,陶朱,薛赛凤,罗春,欧瑜,张建新.“Investigation of Complex of Cucurbit [6, 7, 8]urils with Adefovir Bis(L-amino acid)Ester Prodrug and Its Anti-HBV Activity,Chinese Journal ofOrganic Chemistry 2010, 5, 675-683 ”论文获得贵州省首届优秀医学学术论文三等奖,获奖时间2011年2月,授奖部门贵州省卫生厅、贵州省科教办。
2、傅晓钟贵州省第九批优秀青年科技人才培养对象,获奖时间2013年4月,授奖部门贵州省优秀青年科技人才培养领导小组。
3、傅晓钟贵州省优秀教师,获奖时间2013年9月,授奖部门贵州省教育厅,贵州省人力资源与社会保障厅。